Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that more research is needed to understand and treat Beard Alopecia Areata due to limited current knowledge and evidence.

Skin conditions can signal heart issues, highlighting the need for integrated care.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

The study suggests silicon might be important for healthy hair, as less silicon was found in people with hair loss.

COVID-19 can cause or worsen skin issues.

A woman with hair loss had a benign sweat duct tumor found during a scalp biopsy.

The document concludes that skin and nail changes can indicate various underlying health conditions.

Treating vitiligo with stem cells and melanocytes from hair, along with UVB light, works better than without the light.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

The Wnt/β-catenin pathway helps tissue regeneration but can also cause fibrosis, and drugs that inhibit this pathway may aid in healing skin and heart tissues.

Long-standing benign tumors can become cancerous, especially in people with weakened immune systems.

Hair greying is caused by oxidative stress damaging hair follicles and melanocytes.

Melanocyte development from neural crest cells is complex and influenced by many factors, and better understanding could help treat skin disorders.

Folliculitis is an inflammation of hair follicles that requires proper diagnosis and treatment based on the specific cause.

The 308-nm excimer laser is a promising treatment for vitiligo with varying success and mild side effects.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Mice with human skin protein K8 had more skin problems and cancer.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Certain diets can affect skin conditions, but more research is needed to understand these relationships fully.

Hair microRNAs could be effective biomarkers for diagnosing scleroderma.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Many skin patients have mental health issues, but few dermatologists are well-versed in treating these conditions.

Mice lacking fibromodulin have disrupted healing patterns, leading to abnormal skin repair and scarring.

β-blockers can cause skin problems like psoriasis and vitiligo, and doctors should tell patients about these risks.

Higher aldosterone levels link to hair loss and high blood pressure.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.